Algert Global LLC Catalent, Inc. Transaction History

Algert Global LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$85.88 - $105.36 $480,069 - $588,962	-5,590 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$72.74 - $92.5 $195,888 - $249,102	-2,693 Reduced 32.51%	5,590 $479,000
Q2 2020 Aug 12, 2020	BUY	$48.02 - $79.04 $397,749 - $654,688	8,283 New	8,283 $607,000
Q4 2017 Feb 01, 2018	SELL	$37.27 - $43.02 $725,646 - $837,599	-19,470 Closed	0 $0
Q3 2017 Nov 17, 2017	BUY	$33.75 - $41.67 $657,112 - $811,314	19,470	19,470 $777,000

515

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.